{"id":13976,"date":"2025-02-23T02:18:44","date_gmt":"2025-02-23T02:18:44","guid":{"rendered":"https:\/\/inbudgetalerts.com\/?p=13976"},"modified":"2025-02-23T02:18:44","modified_gmt":"2025-02-23T02:18:44","slug":"pfizer-no-more-growth-still-a-worthy-dividend-buy-nysepfe","status":"publish","type":"post","link":"https:\/\/inbudgetalerts.com\/?p=13976","title":{"rendered":"Pfizer: No More Growth &#8211; Still A Worthy Dividend Buy (NYSE:PFE)"},"content":{"rendered":"<div data-test-id=\"author-root\">\n<p class=\"mb-12 text-medium-2-r text-share-text-3\">This article was written by<\/p>\n<div class=\"mb-12 flex justify-between\">\n<div class=\"flex\">\n<div class=\"flex shrink-0 items-center justify-center relative size-44 rounded-full\" data-test-id=\"user-pic-wrapper\"><\/div>\n<\/div>\n<p><button data-state-text=\"Following\" aria-label=\"Follow\" class=\"ihjjQ py-8 px-18 o7ZP8 ml-8 mt-0 shrink-0 self-baseline text-small-b relative inline-flex cursor-pointer select-none items-center whitespace-nowrap break-words transition-colors hover:no-underline motion-reduce:transition-none rounded-4 border-black bg-black text-white hover:bg-black-70 disabled:border-transparent disabled:bg-black-20 dark:border-black-10 dark:bg-black-10 dark:text-black dark:hover:border-black-10 dark:hover:bg-black-10 dark:disabled:bg-black-30 w-auto min-h-28 justify-center border px-12 py-1 text-medium-r\" data-test-id=\"follow-button\" type=\"button\"><span class=\"\"><span aria-hidden=\"true\" class=\"wMAFB relative flex justify-center\" data-state-placeholder=\"Following\"><span class=\"absolute\">Follow<\/span><\/span><\/span><\/button><\/p>\n<\/div>\n<div class=\"text-medium-2-r\">\n<div class=\"relative\">\n<div class=\"relative overflow-hidden\" style=\"max-height:100%\">\n<div>\n<p>I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div data-test-id=\"content-container\">\n<p id=\"a-disclosure\"><b>Analyst\u2019s Disclosure:<\/b> <span>I\/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.<\/span> <span id=\"top-business-disclosure\"> I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. <\/span><\/p>\n<p>The analysis is provided exclusively for informational purposes and should not be considered professional investment advice. Before investing, please conduct personal in-depth research and utmost due diligence, as there are many risks associated with the trade, including capital loss.<\/p>\n<p id=\"a-disclosure-more\"><strong>Seeking Alpha&#8217;s Disclosure:<\/strong> Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.<\/p>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/seekingalpha.com\/article\/4760934-pfizer-no-more-growth-still-a-worthy-dividend-buy?source=feed_all_articles\" target=\"_blank\" rel=\"noopener\" rel=\"nofollow\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This article was written by Follow I am a full-time analyst interested in a wide range of stocks. With my unique insights&#8230;<\/p>\n","protected":false},"author":1,"featured_media":13977,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":{"0":"post-13976","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pfizer: No More Growth - Still A Worthy Dividend Buy (NYSE:PFE) | InBudgetAlerts<\/title>\n<meta name=\"description\" content=\"This article was written byFollowI am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inbudgetalerts.com\/?p=13976\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer: No More Growth - Still A Worthy Dividend Buy (NYSE:PFE) | InBudgetAlerts\" \/>\n<meta property=\"og:description\" content=\"This article was written byFollowI am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inbudgetalerts.com\/?p=13976\" \/>\n<meta property=\"og:site_name\" content=\"InBudgetAlerts\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-23T02:18:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2025\/02\/image_1359132050.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/inbudgetalerts.com\/?p=13976#article\",\"isPartOf\":{\"@id\":\"https:\/\/inbudgetalerts.com\/?p=13976\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/inbudgetalerts.com\/#\/schema\/person\/5fadb0c23fa3bfd2762b1a5dcce46da3\"},\"headline\":\"Pfizer: No More Growth &#8211; Still A Worthy Dividend Buy (NYSE:PFE)\",\"datePublished\":\"2025-02-23T02:18:44+00:00\",\"dateModified\":\"2025-02-23T02:18:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/inbudgetalerts.com\/?p=13976\"},\"wordCount\":283,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/inbudgetalerts.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/inbudgetalerts.com\/?p=13976#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/inbudgetalerts.com\/?p=13976\",\"url\":\"https:\/\/inbudgetalerts.com\/?p=13976\",\"name\":\"Pfizer: No More Growth - Still A Worthy Dividend Buy (NYSE:PFE) | InBudgetAlerts\",\"isPartOf\":{\"@id\":\"https:\/\/inbudgetalerts.com\/#website\"},\"datePublished\":\"2025-02-23T02:18:44+00:00\",\"dateModified\":\"2025-02-23T02:18:44+00:00\",\"description\":\"This article was written byFollowI am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide\",\"breadcrumb\":{\"@id\":\"https:\/\/inbudgetalerts.com\/?p=13976#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/inbudgetalerts.com\/?p=13976\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/inbudgetalerts.com\/?p=13976#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/inbudgetalerts.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer: No More Growth &#8211; Still A Worthy Dividend Buy (NYSE:PFE)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/inbudgetalerts.com\/#website\",\"url\":\"https:\/\/inbudgetalerts.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/inbudgetalerts.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/inbudgetalerts.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/inbudgetalerts.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/inbudgetalerts.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/inbudgetalerts.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/inbudgetalerts.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/inbudgetalerts.com\/#\/schema\/person\/5fadb0c23fa3bfd2762b1a5dcce46da3\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/inbudgetalerts.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/inbudgetalerts.com\"],\"url\":\"https:\/\/inbudgetalerts.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer: No More Growth - Still A Worthy Dividend Buy (NYSE:PFE) | InBudgetAlerts","description":"This article was written byFollowI am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inbudgetalerts.com\/?p=13976","og_locale":"en_US","og_type":"article","og_title":"Pfizer: No More Growth - Still A Worthy Dividend Buy (NYSE:PFE) | InBudgetAlerts","og_description":"This article was written byFollowI am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide","og_url":"https:\/\/inbudgetalerts.com\/?p=13976","og_site_name":"InBudgetAlerts","article_published_time":"2025-02-23T02:18:44+00:00","og_image":[{"width":1536,"height":1300,"url":"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2025\/02\/image_1359132050.jpg","type":"image\/jpeg"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/inbudgetalerts.com\/?p=13976#article","isPartOf":{"@id":"https:\/\/inbudgetalerts.com\/?p=13976"},"author":{"name":"Press Room","@id":"https:\/\/inbudgetalerts.com\/#\/schema\/person\/5fadb0c23fa3bfd2762b1a5dcce46da3"},"headline":"Pfizer: No More Growth &#8211; Still A Worthy Dividend Buy (NYSE:PFE)","datePublished":"2025-02-23T02:18:44+00:00","dateModified":"2025-02-23T02:18:44+00:00","mainEntityOfPage":{"@id":"https:\/\/inbudgetalerts.com\/?p=13976"},"wordCount":283,"commentCount":0,"publisher":{"@id":"https:\/\/inbudgetalerts.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/inbudgetalerts.com\/?p=13976#respond"]}]},{"@type":"WebPage","@id":"https:\/\/inbudgetalerts.com\/?p=13976","url":"https:\/\/inbudgetalerts.com\/?p=13976","name":"Pfizer: No More Growth - Still A Worthy Dividend Buy (NYSE:PFE) | InBudgetAlerts","isPartOf":{"@id":"https:\/\/inbudgetalerts.com\/#website"},"datePublished":"2025-02-23T02:18:44+00:00","dateModified":"2025-02-23T02:18:44+00:00","description":"This article was written byFollowI am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide","breadcrumb":{"@id":"https:\/\/inbudgetalerts.com\/?p=13976#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inbudgetalerts.com\/?p=13976"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/inbudgetalerts.com\/?p=13976#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inbudgetalerts.com\/"},{"@type":"ListItem","position":2,"name":"Pfizer: No More Growth &#8211; Still A Worthy Dividend Buy (NYSE:PFE)"}]},{"@type":"WebSite","@id":"https:\/\/inbudgetalerts.com\/#website","url":"https:\/\/inbudgetalerts.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/inbudgetalerts.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inbudgetalerts.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/inbudgetalerts.com\/#organization","name":"Fintech Advance","url":"https:\/\/inbudgetalerts.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/inbudgetalerts.com\/#\/schema\/logo\/image\/","url":"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/inbudgetalerts.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/inbudgetalerts.com\/#\/schema\/person\/5fadb0c23fa3bfd2762b1a5dcce46da3","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/inbudgetalerts.com\/#\/schema\/person\/image\/","url":"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/inbudgetalerts.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/inbudgetalerts.com"],"url":"https:\/\/inbudgetalerts.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=\/wp\/v2\/posts\/13976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13976"}],"version-history":[{"count":1,"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=\/wp\/v2\/posts\/13976\/revisions"}],"predecessor-version":[{"id":13978,"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=\/wp\/v2\/posts\/13976\/revisions\/13978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=\/wp\/v2\/media\/13977"}],"wp:attachment":[{"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inbudgetalerts.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}